FDA Clearance Tracker · P960009-S351
Deep Brain Stimulation (DBS) Therapy for Epilepsy
Last checked: Nov 20, 2026Latest source record: Jul 24, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Jul 24, 2019
Approved
Time to decision
61 days
Received May 24, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P960009-S351
- Device name
- Deep Brain Stimulation (DBS) Therapy for Epilepsy
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- May 24, 2019
- Decided
- Jul 24, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P960009
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of the revised protocol for the post-approval study (PAS) protocol.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.